Immunic, Inc. (IMUX)

Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $67.52 million. The enterprise value is $33.62 million.

Market Cap	67.52M
Enterprise Value	33.62M

Important Dates

The next estimated earnings date is Saturday, February 14, 2026, after market close.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Immunic has 120.28 million shares outstanding. The number of shares has increased by 53.56% in one year.

Current Share Class	120.28M
Shares Outstanding	120.28M
Shares Change (YoY)	+53.56%
Shares Change (QoQ)	+96.55%
Owned by Insiders (%)	1.44%
Owned by Institutions (%)	39.24%
Float	101.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.49
P/TBV Ratio	6.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.08.

Current Ratio	1.31
Quick Ratio	1.17
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -398.50% and return on invested capital (ROIC) is -246.99%.

Return on Equity (ROE)	-398.50%
Return on Assets (ROA)	-125.08%
Return on Invested Capital (ROIC)	-246.99%
Return on Capital Employed (ROCE)	-993.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.44% in the last 52 weeks. The beta is 1.48, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-47.44%
50-Day Moving Average	0.71
200-Day Moving Average	0.87
Relative Strength Index (RSI)	33.09
Average Volume (20 Days)	1,450,582

Short Selling Information

The latest short interest is 5.59 million, so 4.65% of the outstanding shares have been sold short.

Short Interest	5.59M
Short Previous Month	5.72M
Short % of Shares Out	4.65%
Short % of Float	5.49%
Short Ratio (days to cover)	4.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-105.53M
Pretax Income	-103.05M
Net Income	-103.05M
EBITDA	-105.37M
EBIT	-105.53M
Earnings Per Share (EPS)	-$0.78

Balance Sheet

The company has $35.13 million in cash and $792,000 in debt, giving a net cash position of $34.34 million or $0.29 per share.

Cash & Cash Equivalents	35.13M
Total Debt	792,000
Net Cash	34.34M
Net Cash Per Share	$0.29
Equity (Book Value)	10.50M
Book Value Per Share	0.11
Working Capital	9.19M

Cash Flow

In the last 12 months, operating cash flow was -$89.49 million and capital expenditures -$153,000, giving a free cash flow of -$89.64 million.

Operating Cash Flow	-89.49M
Capital Expenditures	-153,000
Free Cash Flow	-89.64M
FCF Per Share	-$0.75

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.56%
Shareholder Yield	-53.56%
Earnings Yield	-151.63%
FCF Yield	-131.90%

Analyst Forecast

The average price target for Immunic is $6.00, which is 968.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	968.95%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1